VRDN
Viridian Therapeutics Inc
22.10$
+2.5%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -41.3% | +31.5% | +20.0% | +109.5% | -46.8% | -76.5% | +182.2% | -40.2% | -82.3% | -3.8% | +23,359.9% | |
| – | -23.8% | +3.1% | +670.1% | +55.0% | +7.8% | -13.7% | -97.8% | +21.8% | +75.1% | -6.2% | -6.5% | |
| – | -93.9% | +1,095.5% | -2,079.7% | – | – | -710.9% | – | -40.2% | -82.3% | -3.8% | +23,359.9% | |
| – | +242.0% | -11.4% | +2,109.8% | +55.0% | +14.4% | -18.7% | +101.0% | +77.4% | +58.3% | +49.1% | +42.3% | |
| – | +9.4% | +2.8% | +38.0% | +1.3% | +5.4% | +13.9% | +94.5% | +36.3% | +170.0% | -35.7% | +56.0% | |
| – | +39.9% | -7.0% | +191.8% | +35.8% | +12.0% | +79.0% | -0.5% | +64.6% | +87.2% | +17.5% | +45.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -86.2% | -32.6% | +303.2% | +127.9% | -4.4% | -39.2% | -99.4% | +16,100.0% | +280.0% | +64.9% | +62.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +0.0% | +1,220.0% | -56.4% | -50.8% | -98.9% | -147,766.7% | – | -1,554.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.